Stocktoria
GE HealthCare Technologies Inc. GEHC
Nasdaq · stock · X-Ray Apparatus & Tubes & Related Irradiation Apparatus · website · IPO 2022-12-15 · LEI
GE HealthCare Technologies Inc. financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $20.6B | $19.7B | $19.6B | $18.3B |
| Gross profit | $8.2B | $8.2B | $7.9B | $7.2B |
| R&D expense | $1.3B | $1.3B | $1.2B | $1.0B |
| SG&A expense | $4.2B | $4.3B | $4.3B | $3.6B |
| Operating income | $2.8B | $2.6B | $2.4B | $2.5B |
| Income tax | $614.0M | $531.0M | $743.0M | $563.0M |
| Net income | $2.1B | $2.0B | $1.6B | $1.9B |
| EPS (diluted) | $4.55 | $4.34 | $3.03 | $4.22 |
| Operating cash flow | $2.0B | $2.0B | $2.1B | $2.1B |
| Cash & equivalents | $4.5B | $2.9B | $2.5B | $1.4B |
| Inventory | $2.2B | $1.9B | $2.0B | $2.2B |
| Total assets | $36.9B | $33.1B | $32.5B | $27.5B |
| Total liabilities | $26.3B | $24.4B | $25.1B | $17.9B |
| Shareholders' equity | $10.4B | $8.5B | $7.1B | $9.4B |
Growth · year-over-year · Revenue CAGR 4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +4.8% | +0.6% | +6.6% | — |
| Net income growth | +4.6% | +27.1% | -18.2% | — |
| EPS growth | +4.8% | +43.2% | -28.2% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.